Detalhe da pesquisa
1.
Therapy with pembrolizumab in treatment-naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer.
Int J Cancer
; 152(10): 2145-2152, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36594580
2.
Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours.
Br J Clin Pharmacol
; 89(3): 1046-1055, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36131603
3.
Patients in phase 1 cancer trials: psychological distress and understanding of trial information.
Acta Oncol
; 61(3): 341-348, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34709958
4.
A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours.
Br J Cancer
; 124(4): 728-735, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230210
5.
Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia.
Blood
; 131(8): 855-863, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29203585
6.
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan.
Acta Oncol
; 62(12): 1979-1982, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37934081
7.
Concordance of Mutation Detection in Circulating Tumor DNA in Early Clinical Trials Using Different Blood Collection Protocols.
Clin Lab
; 63(10): 1755-1759, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29035458
8.
Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 - a retrospective case series.
Int J Neurosci
; 126(11): 1002-6, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26365467
9.
TOP1 gene copy numbers are increased in cancers of the bile duct and pancreas.
Scand J Gastroenterol
; 50(4): 485-94, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25615400
10.
The effect of bevacizumab on vestibular schwannoma tumour size and hearing in patients with neurofibromatosis type 2.
Eur Arch Otorhinolaryngol
; 272(12): 3627-33, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25421643
11.
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors.
Clin Cancer Res
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630781
12.
Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review.
Scand J Gastroenterol
; 48(8): 899-905, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23834019
13.
Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy.
Front Genet
; 14: 1058605, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37035751
14.
Harms of exercise training in patients with cancer undergoing systemic treatment: a systematic review and meta-analysis of published and unpublished controlled trials.
EClinicalMedicine
; 59: 101937, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096190
15.
A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma.
Clin Cancer Res
; 28(3): 452-460, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34728525
16.
Prevalence of HER2 overexpression and amplification in squamous cell carcinoma of the esophagus: A systematic review and meta-analysis.
Crit Rev Oncol Hematol
; 161: 103339, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33865993
17.
HER2 Positivity in Histological Subtypes of Salivary Gland Carcinoma: A Systematic Review and Meta-Analysis.
Front Oncol
; 11: 693394, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34249747
18.
Perioperative exercise training for patients with gastrointestinal cancer undergoing surgery: A systematic review and meta-analysis.
Eur J Surg Oncol
; 47(12): 3028-3039, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34294466
19.
[Circulating tumour DNA in the treatment of cancer].
Ugeskr Laeger
; 183(32)2021 08 09.
Artigo
em Dinamarquês
| MEDLINE | ID: mdl-34378526
20.
Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug-drug interaction study in patients with ALK + advanced tumors.
Cancer Chemother Pharmacol
; 87(4): 475-486, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33394101